EUVIMEDEUVIMED entdecken
Open Access

Development, Pharmacokinetics and Antimalarial Evaluation of Dose Flexible 3D Printlets of Dapsone for Pediatric Patients

Adnan A Khan, Tahir Khuroo, Eman M Mohamed, Sathish Dharani, Kayalar Canberk, Xiaoyu Zhang, Lamba Omar Sangaré, Mathew A Kuttolamadom, Allison C Rice-Ficht, Ziyaur Rahman

AAPS PharmSciTech · 2024

DOI: 10.1208/s12249-024-02935-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift AAPS PharmSciTech, 2024. Verfasst von Adnan A Khan und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Engineering Medicine, Texas A&M University, Houston, Texas, 77030, USA. Hauptthemen laut MEDLINE: Antimalarials, Rats, Sprague-Dawley, Dapsone, Printing, Three-Dimensional. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The focus of current studies was to fabricate dose flexible printlets of dapsone (DDS) for pediatric patients by selective laser sintering (SLS) 3D printing method, and evaluate its physicochemical, patient in-use stability, and pharmacokinetic attributes. Eight formulations were fabricated using Kollicoat® IR, Eudragit® L-100-55 and StarCap®as excipients and evaluated for hardness, disintegration, dissolution, amorphous phase by differential scanning calorimetry and X-ray powder diffraction, in-use stability at 30 oC/75% RH for a month, and pharmacokinetic study in Sprague Dawley rats. The hardness, and disintegration of the printlets varied from 2.6±1.0 (F4) to 7.7±0.9 (F3) N and 2.0±0.4 (F2) to 7.6±0.6 (F3) sec, respectively. The drug was partially present as an amorphous form in the printlets. The drug was completely (>85%) dissolved in 20 min. No change in drug form or dissolution extent was observed after storage at in use condition. Pharmacokinetic profiles of both formulations (tablets and printlets) were almost superimposable with no statistical difference in pharmacokinetic parameters (Tmax, Cmax, and AUC0-¥)between formulations (p>0.05). Values of EC50 (half maximal effective concentration) and EC90 (maximal concentration inducing 90% maximal response) were 0.50±0.15 and 1.32±0.26 mM, 0.41±0.06 and 1.11±0.21, and 0.42±0.13 and 1.36±0.19 mM for DDS, printlet and tablet formulations, respectively, and differences were statistically insignificant (p>0.05). In conclusion, tablet and printlet formulations are expected to be clinical similar, thus clinically interchangeable.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AntimalarialsRats, Sprague-DawleyDapsonePrinting, Three-DimensionalAnimalsRatsChemistry, PharmaceuticalSolubilityMaleExcipientsHumansTabletsDrug StabilityChildCalorimetry, Differential ScanningDrug CompoundingX-Ray Diffraction

Stichwörter der Autor:innen

anti-parasitic efficacydapsonedissolutionpharmacokineticprintletsselective laser sintering

Substanzen

AntimalarialsDapsoneExcipientsTablets

Autor:innen und Institutionen

  • School of Engineering Medicine, Texas A&M University, Houston, Texas, 77030, USA.
  • Texas A&M Health Science Center, Irma Lerma Rangel School of Pharmacy, Texas A&M University, Reynolds Medical Sciences Building, Suite 308, College Station, Texas, 77843, USA.
  • Department of Biochemistry, University of Texas Southwestern Medical Center, Dallas, Texas, 75390, USA.
  • Department of Biology, Texas A&M University, College Station, Texas, 77843, USA.
  • Department of Engineering Technology & Industrial Distribution, College of Engineering, Texas A&M University, College Station, Texas, 77843, USA.
  • Department of Cell Biology and Genetics, School of Medicine, Texas A&M Health Science Center, Texas A&M University, College Station, Texas, 77843, USA.

Förderung

  • NICHD NIH HHS

Zitieren

APA

Khan, A. A., Khuroo, T., Mohamed, E. M., Dharani, S., Canberk, K., Zhang, X., Sangaré, L. O., Kuttolamadom, M. A., Rice-Ficht, A. C., & Rahman, Z. (2024). Development, Pharmacokinetics and Antimalarial Evaluation of Dose Flexible 3D Printlets of Dapsone for Pediatric Patients. AAPS PharmSciTech. https://doi.org/10.1208/s12249-024-02935-2

Vancouver

Khan AA, Khuroo T, Mohamed EM, Dharani S, Canberk K, Zhang X, et al. Development, Pharmacokinetics and Antimalarial Evaluation of Dose Flexible 3D Printlets of Dapsone for Pediatric Patients. AAPS PharmSciTech. 2024. doi:10.1208/s12249-024-02935-2

BibTeX
@article{Khan2024,
  author = {Khan, Adnan A and Khuroo, Tahir and Mohamed, Eman M and Dharani, Sathish and Canberk, Kayalar and Zhang, Xiaoyu and Sangaré, Lamba Omar and Kuttolamadom, Mathew A and Rice-Ficht, Allison C and Rahman, Ziyaur},
  title = {Development, Pharmacokinetics and Antimalarial Evaluation of Dose Flexible 3D Printlets of Dapsone for Pediatric Patients},
  journal = {AAPS PharmSciTech},
  year = {2024},
  doi = {10.1208/s12249-024-02935-2}
}
Kostenlos starten →